Drug profile · INN
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
CELLDEMIC
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (CELLDEMIC) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (CELLDEMIC) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)
Brand CELLDEMIC
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)?
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (CELLDEMIC) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)?
CELLDEMIC is a marketed brand name for zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures). Check FDA Drugs@FDA for the current US label holder and prescribing information.